Parkinson's Disease Clinical Trial
Official title:
Immediate Effects of Treadmill Gait Training Combined With Cognitive Tasks in Individuals With Parkinson's Disease: Randomized Controlled Trial
Treadmill gait training combined with cognitive tasks in Parkinson's disease.
This is a trial involving subjects diagnosed with Parkinson's disease, in accordance with
guidelines established by the London Brain Bank.
Individuals often must execute more than one task simultaneously during everyday life. When
different activities that require attention are performed at the same time, a situation
called Dual Task occurs.
Under normal conditions, motor cortex areas (primary motor cortex, pre-motor cortex and
supplementary motor area) are responsible for selecting the range of movements in a given
action sequence, in accordance with the demands of the task and environmental restrictions,
and after the onset of movements brought about by the motor cortex, the basal nuclei
continue execution, leaving the motor cortex free for other tasks that require attention.
However, in Parkinson's disease, automaticity promoted by basal nuclei is compromised and
constant conscious control becomes necessary during gait. Thus, when an activity concurrent
with this function is performed, the frontal regions become dedicated to the secondary task
and gait is predominantly controlled by defective basal nuclei, which generates negative
Dual Task interference on gait.
Given the poor gait quality assessed in DT situations, individuals with PD have been
instructed to avoid these circumstances. By contrast, recent evidence has demonstrated that
gait training in conjunction with to secondary activities is capable of improving variables
related to DT gait performance in PD.
Considering that treadmill gait training provides greater regularity and automaticity,
allowing subjects to divert their attention to cognitive functions, this study hypothesizes
that DT treadmill gait training combined with cognitive tasks will promote better gait
performance in individuals with PD.
Patients were invited to participate in the study from phone calls. They were recruited from
the service list in Neurology at Hospital Onofre Lopes, in Natal -Brazil. Randomization of
individuals with respect to participation in the groups was done via the randomization.com
website, by a person unfamiliar with the training procedures (rater 1), who assigned a color
(yellow or green) to each group. Opaque envelopes were numbered and separated, and inside
each envelope was a piece of paper containing the word "yellow" or "green". As a new patient
arrived for training, rater 2 opened an envelope and was only aware of the color code of
that particular patient. Rater 3, the lead researcher, conducted the assessment and
re-assessment procedures. The color codes were maintained in secrecy by raters 1 and 2
throughout the entire study.
Cognitive function was assessed using the Montreal Cognitive Assessment Scale (MoCA). Its
score ranges between 0 and 30, covering aspects related to visuospatial and executive
functions, naming, memory, attention, language, abstraction, delayed recall, as well as
temporal and spatial orientation. Higher scores correspond to greater cognitive function.
Disease severity was classified according to guidelines proposed by the Modified Hoehn and
Yahr Scale, composed of seven stages, allowing categorization of both sides of the body as
to balance and physical independence. Its scores range from 0 (no signs of the disease) to 5
points (confined to bed or wheelchair).
Assessment of degree of motor and functional impairment was obtained using the Unified
Parkinson's Disease Rating Scale (UPDRS). This study used only items 2 and 3 of the scale,
related to ADLs and motor exploration, whose scores correspond to 52 and 56, respectively.
Kinematic assessment of overground gait was performed by the Qualisys Motion Capture Systems
(Qualisys Medical AB, 411 13 Gothenburg, Sweden), which records the spatiotemporal variables
of gait, as well as angular variations of hip, knee and ankle joints. This system is
composed of eight cameras that emit and capture infrared light. The light is reflected by
spherical passive markers positioned on bony prominences and standard body segments, in
order to capture lower limb data. The cameras are connected to a computer, where the images
collected are stored. Data captured in two-dimensional imaging are processed by Qualisys
Track Manager 2.6 acquisition software, which recognizes marker positioning and, based on
the combination of images from at least two cameras connected in series, enables the
generation of three-dimensional coordinates of movement. To that end, data are transported
by 3D visual software (C-Motion, Rockville, MD, USA), version Basic/RT 3.99.25.8), which
allows the reconstruction and three-dimensional analysis of the body segments marked,
thereby recording the movements executed during gait.
For kinematic assessment, we used 15 and 19 mm-diameter markers positioned bilaterally on
the following structures: iliac crest, greater trochanter, medial and lateral epicondyle of
the femur, medial and lateral malleoli, calcaneus, head of the first metatarsal and head of
the fifth metatarsal. These markers are denominated anatomical, since their function is to
demarcate axial joints, allowing different segments to be delimited.
The marks that guide the trajectory of segments are classified as tracking, and are arranged
in fours on the rectangular base (cluster). The markers were placed on the base of the
sacrum, on the middle third of the thigh and middle third of the leg. Anatomical markers
were fixed with double-faced adhesive tape and reinforced with surgical tape, while tracking
markers were coupled to the body segments with elastic bands and Velcro. Markers were
colored by the same rater on all the volunteers, in order to preserve the reliability of the
marking.
For gait training, we used an electric Gait Trainer 2 treadmill (Biodex Medical System, NY,
USA), with a walking area measuring 160 x 51 centimeters (cm), and equipped with a bar for
upper extremity support, heart monitoring by bioimpedance sensors located on the bar and a
Polar Telemetry system (POLAR, USA). Coupled to the treadmill is an Unweighing System
(Biodex Medical System, NY, USA), composed of a vertical standing frame that carries the
weight supported by means of a harness. However, the patients did not use the weight support
system in this study and the harness was used only as a safety precaution during the
training sessions.
The study procedures were performed over two days, the first for assessment and the second
for the intervention with immediate reassessment. On the first day, the Montreal Cognitive
Assessment (MoCA), Unified Parkinson's Disease Rating Scale and Modified Hoehn and Yahr
Scale were applied. Next, weight and height were recorded. Finally, kinematic assessment of
overground DT gait was carried out. On the second day, the subjects were submitted to
treadmill training and kinematic reassessment of overground DT gait. Assessment occurred one
day after training.
At the onset of kinematic assessment, after marker placement and equipment calibration,
static collection was performed to inform the system regarding body segment positioning and
enable subsequent construction of the biomechanical model. The individual remained in the
orthostatic position, with arms crossed over their chest, feet apart and pointing towards
one of the cameras. Subjects were filmed for 3 seconds in this position. Next, the
anatomical markers were removed in order to perform dynamic captures. Only tracking markers
of thigh and leg segments remained in place, as well as those on the head of the fifth
metatarsal, lateral malleolus and calcaneus, which correspond to the foot segment.
At each dynamic capture, the individuals were instructed to cover a distance of 8 meters,
walking at maximum speed, while performing a cognitive task. During each 8-meter lap a
letter was randomly drawn and the individual was asked to say as many words as possible
starting with that letter. When the patients unable to recall words, the subjects were also
instructed not to stop, but rather to continue walking and trying to remember. Ten dynamic
collections were conducted.
On the next day, the Experimental Group (n=11) underwent treadmill gait training
simultaneously to a protocol of cognitive tasks involving a number of attention and
executive functions, such as verbal fluency, working memory and spatial planning. The
protocol was created specifically for this study, based on cognitive activities proposed in
previous studies. The training sessions lasted 20 minutes. The first three minutes allowed
subjects to familiarize themselves with the treadmill. From the 4th minute onward, the
volunteer walked for 1 minute while performing cognitive tasks, and in the following minute,
only walked. Thus, the 17 remaining minutes on the treadmill alternated between one minute
of treadmill training combined with a cognitive task and the following minute only treadmill
training. The Control Group (n=11) underwent only treadmill training. Training lasted 20
minutes for both groups. Treadmill gait speed for both groups was that reported by the
patient as the fastest possible speed while maintaining a suitable comfort level. Vital
signs (heart rate and blood pressure) were monitored before, during and after the session.
Immediately after treadmill training, DT overground gait was reassessed, using ten dynamics
captures, the same procedures used on the first day.
Kinematic data processing was conducted with Qualisys Track Manager 2.6 software (QTM),
where markers were named and their trajectories defined. Next, the data obtained in QTM were
exported to the Visual 3D program, where three-dimensional reconstruction of the biochemical
model was carried out.
Statistical analysis was conducted using the Statistical Package for the Social Sciences
(SPSS), version 19.0. Before the analysis of each group, data distribution normality was
verified by applying descriptive statistics procedures and the Kolmogorov-Smirnov (K-S)
test.
Measures of central tendency and dispersion were used to illustrate clinical, demographic
and anthropometric data. For data with normal distribution, the paired t-test was used to
compare intragroup spatiotemporal and angular variables, while the student's t-test for
independent samples was applied to compare intergroup variables. The Mann-Whitney test was
used for data with non-normal distribution. A significance level of 5% was set for all these
tests.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Completed |
NCT02939391 -
A Study of KW-6356 in Subjects With Early Parkinson's Disease
|
Phase 2 | |
Terminated |
NCT02924194 -
Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease
|
N/A |